Form D — Angiex, Inc.

0001710380-25-000005 · filed Sep 26, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06c
Reported offering amount: $28,409,510
Reported amount sold: $21,991,695
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Angiex, Inc.
CIK: 1710380
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 150 Cambridge Park Drive, 5th Floor
CAMBRIDGE, MA 02140
Phone: 857-203-7808

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Paul Jaminet · Executive Officer

Cambridge, MA Find on LinkedIn ↗
Amal Amin · Director

Cambridge, MA Find on LinkedIn ↗
Jason Camm · Director

Cambridge, MA Find on LinkedIn ↗
Haijing Guo · Director

Cambridge, MA Find on LinkedIn ↗
Fabian Hansen · Director

Cambridge, MA Find on LinkedIn ↗
Tina Neel · Director

Cambridge, MA Find on LinkedIn ↗
Jonathan Adams · Director

Cambridge, MA Find on LinkedIn ↗
Iain Dukes · Director

Cambridge, MA Find on LinkedIn ↗
Errik Anderson · Director

Cambridge, MA Find on LinkedIn ↗

Other filings from this issuer

Form D — Aug 14, 2025 — 0001710380-25-000003

View the original filing on SEC EDGAR ↗